Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Gilead applies for PrEP approval in Canada

Gilead has applied to Health Canada for Truvada to be approved as PrEP – HIV pre-exposure prophylaxis. Truvada is not approved as PrEP yet in Canada which means doctors must prescribe it off-label and it is not yet on any provincial drug plan formularies outside of Quebec. Gilead Pharmaceuticals has now formally submitted its application to Health Canada for Truvada to also be approved for a preventative indication. Much of this can be attributed to a petition launched in April by several HIV and gay men’s health organizations in Canada, calling on Gilead to apply to Health Canada.

Published
27 August 2015
From
Homoculture.ca
Where Do I Fit In? PrEP and Transgender Men

There aren’t guidelines about Truvada-based PrEP use for transgender men who have sex with men because there haven’t been any studies specifically looking at how the drug works in our bodies. In fact, major PrEP clinical efficacy trials have not included transgender men in any of their study populations to date.

Published
26 August 2015
From
BETA blog
High rate of mental health issues found among some PEP users

Researchers in Boston found that people who sought PEP had a high rate of mental health issues. The Boston team strongly encourages healthcare providers who prescribe PEP to screen and treat potential patients for mental health issues.

Published
26 August 2015
From
CATIE
PrEPosterous gender health inequality?

PrEP (Pre Exposure Prophylaxis) is a highly effective “game changer". Women should get excited right? Well, perhaps not – it’s not yet clear if we’ll get our hands on it.

Published
20 August 2015
From
NAT
AIDS Healthcare Foundation Cedes Ground in Anti-PrEP Fight

AIDS Healthcare Foundation, which has long waged a vociferous and largely isolated battle against Truvada as PrEP, has finally begun to capitulate, offering measured support for the HIV prevention method.

Published
19 August 2015
From
AIDSMeds
People with hepatitis B can safely use Truvada PrEP for HIV prevention

People with hepatitis B virus (HBV) infection did not experience liver inflammation 'flares' or other adverse events when they used or stopped using Truvada for HIV pre-exposure prophylaxis

Published
14 August 2015
By
Liz Highleyman
Study sheds light on how tenofovir is processed in different body tissues

Tenofovir, which is widely used for HIV treatment and prevention, is activated in a tissue-specific manner, being processed by different enzymes in immune cells, the vagina and

Published
13 August 2015
By
Liz Highleyman
First Brazilian PrEP data reinforce evidence that PrEP is most used by those at greatest risk

The first data from a Brazilian open-label demonstration project of HIV pre-exposure prophylaxis (PrEP) show, in common with several other studies presented at the Eighth IAS Conference

Published
11 August 2015
By
Gus Cairns
PrEP Seen as a Big Part of White House's New HIV Strategy

HIV awareness groups say providing better access to the drug is essential to lower the rate of infection.

Published
10 August 2015
From
Healthline
Indiana HIV outbreak offers lessons about containing local outbreaks and need for harm reduction

An early-2015 outbreak of HIV and hepatitis C virus (HCV) in rural Indiana, USA, linked to injection of prescription opiates, offers a good example of how to

Published
10 August 2015
By
Liz Highleyman
← First12345...61Next →

Filter by country